Bausch Health Cos Research and Development Expenses 2010-2024 | BHC
Bausch Health Cos research and development expenses from 2010 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
Bausch Health Cos Annual Research and Development Expenses
(Millions of US $) |
| 2023 |
$604 |
| 2022 |
$529 |
| 2021 |
$465 |
| 2020 |
$452 |
| 2019 |
$471 |
| 2018 |
$413 |
| 2017 |
$361 |
| 2016 |
$421 |
| 2015 |
$334 |
| 2014 |
$246 |
| 2013 |
$157 |
| 2012 |
$269 |
| 2011 |
$66 |
| 2010 |
$68 |
| 2009 |
$48 |
Bausch Health Cos Quarterly Research and Development Expenses
(Millions of US $) |
| 2024-09-30 |
$146 |
| 2024-06-30 |
$156 |
| 2024-03-31 |
$151 |
| 2023-12-31 |
$152 |
| 2023-09-30 |
$153 |
| 2023-06-30 |
$156 |
| 2023-03-31 |
$143 |
| 2022-12-31 |
$142 |
| 2022-09-30 |
$133 |
| 2022-06-30 |
$127 |
| 2022-03-31 |
$127 |
| 2021-12-31 |
$117 |
| 2021-09-30 |
$121 |
| 2021-06-30 |
$115 |
| 2021-03-31 |
$112 |
| 2020-12-31 |
$119 |
| 2020-09-30 |
$103 |
| 2020-06-30 |
$108 |
| 2020-03-31 |
$122 |
| 2019-12-31 |
$114 |
| 2019-09-30 |
$123 |
| 2019-06-30 |
$117 |
| 2019-03-31 |
$117 |
| 2018-12-31 |
$120 |
| 2018-09-30 |
$107 |
| 2018-06-30 |
$94 |
| 2018-03-31 |
$92 |
| 2017-12-31 |
$90 |
| 2017-09-30 |
$81 |
| 2017-06-30 |
$94 |
| 2017-03-31 |
$96 |
| 2016-12-31 |
$174 |
| 2016-09-30 |
$20 |
| 2016-06-30 |
$124 |
| 2016-03-31 |
$103 |
| 2015-12-31 |
$-13 |
| 2015-09-30 |
$197 |
| 2015-06-30 |
$93 |
| 2015-03-31 |
$56 |
| 2014-12-31 |
$19 |
| 2014-09-30 |
$79 |
| 2014-06-30 |
$75 |
| 2014-03-31 |
$73 |
| 2013-12-31 |
$-69 |
| 2013-09-30 |
$173 |
| 2013-06-30 |
$29 |
| 2013-03-31 |
$24 |
| 2012-12-31 |
$210 |
| 2012-09-30 |
$19 |
| 2012-06-30 |
$18 |
| 2012-03-31 |
$22 |
| 2011-12-31 |
$17 |
| 2011-09-30 |
$17 |
| 2011-06-30 |
$18 |
| 2011-03-31 |
$14 |
| 2010-12-31 |
$18 |
| 2010-09-30 |
$14 |
| 2010-06-30 |
$24 |
| 2010-03-31 |
$13 |
| 2009-12-31 |
$-35 |
| 2009-09-30 |
$23 |
| 2009-06-30 |
$45 |
| 2009-03-31 |
$15 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$3.358B |
$8.757B |
|
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
|
